Insigneo Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Buy |
8,131
+49
| +0.6% | +$3.42K | 0.05% | 307 |
|
|
2025
Q1 | $594K | Sell |
8,082
-40
| -0.5% | -$2.94K | 0.06% | 255 |
|
|
2024
Q4 | $532K | Sell |
8,122
-1,680
| -17% | -$110K | 0.06% | 280 |
|
|
2024
Q3 | $764K | Buy |
9,802
+1,579
| +19% | +$123K | 0.08% | 216 |
|
|
2024
Q2 | $652K | Sell |
8,223
-1,398
| -15% | -$111K | 0.07% | 233 |
|
|
2024
Q1 | $652K | Buy |
+9,621
| New | +$652K | 0.08% | 212 |
|
|
2023
Q4 | – | Sell |
-7,162
| Closed | -$485K | – | 437 |
|
|
2023
Q3 | $485K | Buy |
7,162
+1,023
| +17% | +$69.3K | 0.1% | 193 |
|
|
2023
Q2 | $439K | Buy |
6,139
+137
| +2% | +$9.81K | 0.08% | 220 |
|
|
2023
Q1 | $417K | Buy |
6,002
+125
| +2% | +$8.68K | 0.13% | 163 |
|
|
2022
Q4 | $398K | Buy |
+5,877
| New | +$398K | 0.15% | 150 |
|